Sarla Medical Centre Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 3.95 Cr
as on 18-07-2024
- Company Age 25 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.16 Cr
as on 18-07-2024
- Satisfied Charges ₹ 28.68 Cr
as on 18-07-2024
- Revenue 22.02%
(FY 2023)
- Profit 6.20%
(FY 2023)
- Ebitda 5.19%
(FY 2023)
- Net Worth 46.65%
(FY 2023)
- Total Assets 15.90%
(FY 2023)
About Sarla Medical Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.95 Cr.
The company currently has active open charges totaling ₹1.16 Cr. The company has closed loans amounting to ₹28.68 Cr, as per Ministry of Corporate Affairs (MCA) records.
Babit Kumar and Lalit Kumar serve as directors at the Company.
- CIN/LLPIN
U85110DL1999PTC098269
- Company No.
098269
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Feb 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sarla Medical Centre?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Babit Kumar  | Director | 20-May-2015 | Current |
| Lalit Kumar | Director | 03-Mar-2023 | Current |
Financial Performance and Corporate Structure Insights of Sarla Medical Centre.
Sarla Medical Centre Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.02% increase. The company also saw a slight improvement in profitability, with a 6.2% increase in profit. The company's net worth Soared by an impressive increase of 46.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sarla Medical Centre?
In 2023, Sarla Medical Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Aug 2023 | ₹1.56 M | Open |
Canara Bank Creation Date: 01 Sep 2022 | ₹1.00 Cr | Open |
Others Creation Date: 13 Apr 2022 | ₹15.00 Cr | Satisfied |
How Many Employees Work at Sarla Medical Centre?
Sarla Medical Centre has a workforce of 61 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sarla Medical Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sarla Medical Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
